The Parkinson’s disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson’s disease
Identifieur interne : 000B93 ( Main/Corpus ); précédent : 000B92; suivant : 000B94The Parkinson’s disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson’s disease
Auteurs : K R Chaudhuri ; S. Pal ; A. Dimarco ; C. Whately-Smith ; K. Bridgman ; R. Mathew ; F R Pezzela ; A. Forbes ; B. Högl ; C. TrenkwalderSource :
- Journal of Neurology, Neurosurgery & Psychiatry [ 0022-3050 ] ; 2002-12.
English descriptors
- KwdEn :
Abstract
Background: No formal instruments are available for quantifying sleep problems in Parkinson’s disease. Objective: To develop a new sleep scale to quantify the various aspects of nocturnal sleep problems in Parkinson’s disease, which may occur in up to 96% of affected individuals. Methods: Employing a multidisciplinary team approach, a visual analogue scale was devised addressing 15 commonly reported symptoms associated with sleep disturbance in Parkinson’s disease—the Parkinson’s disease sleep scale (PDSS). In all, 143 patients with Parkinson’s disease completed the PDSS, covering the entire spectrum of disease from newly diagnosed to advanced stage. As controls, 137 age healthy matched subjects also completed the scale. Test–retest reliability was assessed in a subgroup of subjects. The Epworth sleepiness scale was also satisfactorily completed by 103 of the patients with Parkinson’s disease. Results: PDSS scores in the Parkinson group were significantly different from the healthy controls. Patients with advanced Parkinson’s disease had impaired scores compared with early/moderate disease. Individual items of the scale showed good discriminatory power between Parkinson’s disease and healthy controls. Relevant items of the PDSS correlated with excessive daytime sleepiness. The scale showed robust test–retest reliability. Conclusions: This appears to be the first description of a simple bedside screening instrument for evaluation of sleep disturbances in Parkinson’s disease. A combination of subitems may help identify specific aspects of sleep disturbance, which in turn may help target treatment.
Url:
DOI: 10.1136/jnnp.73.6.629
Links to Exploration step
ISTEX:60DA121F2B316A7BC4360ED2A4674FD4E4DA64E4Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">The Parkinson’s disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson’s disease</title><author><name sortKey="Chaudhuri, K R" sort="Chaudhuri, K R" uniqKey="Chaudhuri K" first="K R" last="Chaudhuri">K R Chaudhuri</name><affiliation><mods:affiliation>Department of Neurology, King’s College Hospital, London SE5, UK</mods:affiliation></affiliation></author><author><name sortKey="Pal, S" sort="Pal, S" uniqKey="Pal S" first="S" last="Pal">S. Pal</name><affiliation><mods:affiliation>Department of Neurology, King’s College Hospital, London SE5, UK</mods:affiliation></affiliation></author><author><name sortKey="Dimarco, A" sort="Dimarco, A" uniqKey="Dimarco A" first="A" last="Dimarco">A. Dimarco</name><affiliation><mods:affiliation>Guy’s, King’s and St Thomas’ School of Medicine, King’s College, London, UK</mods:affiliation></affiliation></author><author><name sortKey="Whately Smith, C" sort="Whately Smith, C" uniqKey="Whately Smith C" first="C" last="Whately-Smith">C. Whately-Smith</name><affiliation><mods:affiliation>Independent statistician</mods:affiliation></affiliation></author><author><name sortKey="Bridgman, K" sort="Bridgman, K" uniqKey="Bridgman K" first="K" last="Bridgman">K. Bridgman</name><affiliation><mods:affiliation>Pharmacia Limited, Milton Keynes, UK</mods:affiliation></affiliation></author><author><name sortKey="Mathew, R" sort="Mathew, R" uniqKey="Mathew R" first="R" last="Mathew">R. Mathew</name><affiliation><mods:affiliation>Guy’s, King’s and St Thomas’ School of Medicine, King’s College, London, UK</mods:affiliation></affiliation></author><author><name sortKey="Pezzela, F R" sort="Pezzela, F R" uniqKey="Pezzela F" first="F R" last="Pezzela">F R Pezzela</name><affiliation><mods:affiliation>Department of Neurological Science, University of Rome La Sapienza, Rome, Italy</mods:affiliation></affiliation></author><author><name sortKey="Forbes, A" sort="Forbes, A" uniqKey="Forbes A" first="A" last="Forbes">A. Forbes</name><affiliation><mods:affiliation>University Hospital Lewisham, London, UK</mods:affiliation></affiliation></author><author><name sortKey="Hogl, B" sort="Hogl, B" uniqKey="Hogl B" first="B" last="Högl">B. Högl</name><affiliation><mods:affiliation>Max-Planck Institute of Psychiatry, Munich, Germany</mods:affiliation></affiliation></author><author><name sortKey="Trenkwalder, C" sort="Trenkwalder, C" uniqKey="Trenkwalder C" first="C" last="Trenkwalder">C. Trenkwalder</name><affiliation><mods:affiliation>Department of Clinical Neurophysiology, University of Göttingen, Germany</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:60DA121F2B316A7BC4360ED2A4674FD4E4DA64E4</idno><date when="2002" year="2002">2002</date><idno type="doi">10.1136/jnnp.73.6.629</idno><idno type="url">https://api.istex.fr/document/60DA121F2B316A7BC4360ED2A4674FD4E4DA64E4/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">000B93</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">The Parkinson’s disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson’s disease</title><author><name sortKey="Chaudhuri, K R" sort="Chaudhuri, K R" uniqKey="Chaudhuri K" first="K R" last="Chaudhuri">K R Chaudhuri</name><affiliation><mods:affiliation>Department of Neurology, King’s College Hospital, London SE5, UK</mods:affiliation></affiliation></author><author><name sortKey="Pal, S" sort="Pal, S" uniqKey="Pal S" first="S" last="Pal">S. Pal</name><affiliation><mods:affiliation>Department of Neurology, King’s College Hospital, London SE5, UK</mods:affiliation></affiliation></author><author><name sortKey="Dimarco, A" sort="Dimarco, A" uniqKey="Dimarco A" first="A" last="Dimarco">A. Dimarco</name><affiliation><mods:affiliation>Guy’s, King’s and St Thomas’ School of Medicine, King’s College, London, UK</mods:affiliation></affiliation></author><author><name sortKey="Whately Smith, C" sort="Whately Smith, C" uniqKey="Whately Smith C" first="C" last="Whately-Smith">C. Whately-Smith</name><affiliation><mods:affiliation>Independent statistician</mods:affiliation></affiliation></author><author><name sortKey="Bridgman, K" sort="Bridgman, K" uniqKey="Bridgman K" first="K" last="Bridgman">K. Bridgman</name><affiliation><mods:affiliation>Pharmacia Limited, Milton Keynes, UK</mods:affiliation></affiliation></author><author><name sortKey="Mathew, R" sort="Mathew, R" uniqKey="Mathew R" first="R" last="Mathew">R. Mathew</name><affiliation><mods:affiliation>Guy’s, King’s and St Thomas’ School of Medicine, King’s College, London, UK</mods:affiliation></affiliation></author><author><name sortKey="Pezzela, F R" sort="Pezzela, F R" uniqKey="Pezzela F" first="F R" last="Pezzela">F R Pezzela</name><affiliation><mods:affiliation>Department of Neurological Science, University of Rome La Sapienza, Rome, Italy</mods:affiliation></affiliation></author><author><name sortKey="Forbes, A" sort="Forbes, A" uniqKey="Forbes A" first="A" last="Forbes">A. Forbes</name><affiliation><mods:affiliation>University Hospital Lewisham, London, UK</mods:affiliation></affiliation></author><author><name sortKey="Hogl, B" sort="Hogl, B" uniqKey="Hogl B" first="B" last="Högl">B. Högl</name><affiliation><mods:affiliation>Max-Planck Institute of Psychiatry, Munich, Germany</mods:affiliation></affiliation></author><author><name sortKey="Trenkwalder, C" sort="Trenkwalder, C" uniqKey="Trenkwalder C" first="C" last="Trenkwalder">C. Trenkwalder</name><affiliation><mods:affiliation>Department of Clinical Neurophysiology, University of Göttingen, Germany</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Journal of Neurology, Neurosurgery & Psychiatry</title><title level="j" type="abbrev">J Neurol Neurosurg Psychiatry</title><idno type="ISSN">0022-3050</idno><idno type="eISSN">1468-330X</idno><imprint><publisher>BMJ Publishing Group Ltd</publisher><date type="published" when="2002-12">2002-12</date><biblScope unit="volume">73</biblScope><biblScope unit="issue">6</biblScope><biblScope unit="page" from="629">629</biblScope></imprint><idno type="ISSN">0022-3050</idno></series><idno type="istex">60DA121F2B316A7BC4360ED2A4674FD4E4DA64E4</idno><idno type="DOI">10.1136/jnnp.73.6.629</idno><idno type="href">jnnp-73-629.pdf</idno><idno type="PMID">12438461</idno><idno type="local">0730629</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0022-3050</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>ESS, Epworth sleepiness scale</term><term>MESS, modified Epworth sleepiness scale</term><term>PDSS, Parkinson’s disease sleep scale</term><term>PSQI, Pittsburgh sleep quality index</term><term>Parkinson’s disease</term><term>UPDRS, unified Parkinson’s disease rating scale</term><term>sleep</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Background: No formal instruments are available for quantifying sleep problems in Parkinson’s disease. Objective: To develop a new sleep scale to quantify the various aspects of nocturnal sleep problems in Parkinson’s disease, which may occur in up to 96% of affected individuals. Methods: Employing a multidisciplinary team approach, a visual analogue scale was devised addressing 15 commonly reported symptoms associated with sleep disturbance in Parkinson’s disease—the Parkinson’s disease sleep scale (PDSS). In all, 143 patients with Parkinson’s disease completed the PDSS, covering the entire spectrum of disease from newly diagnosed to advanced stage. As controls, 137 age healthy matched subjects also completed the scale. Test–retest reliability was assessed in a subgroup of subjects. The Epworth sleepiness scale was also satisfactorily completed by 103 of the patients with Parkinson’s disease. Results: PDSS scores in the Parkinson group were significantly different from the healthy controls. Patients with advanced Parkinson’s disease had impaired scores compared with early/moderate disease. Individual items of the scale showed good discriminatory power between Parkinson’s disease and healthy controls. Relevant items of the PDSS correlated with excessive daytime sleepiness. The scale showed robust test–retest reliability. Conclusions: This appears to be the first description of a simple bedside screening instrument for evaluation of sleep disturbances in Parkinson’s disease. A combination of subitems may help identify specific aspects of sleep disturbance, which in turn may help target treatment.</div></front></TEI><istex><corpusName>bmj</corpusName><author><json:item><name>K R Chaudhuri</name><affiliations><json:string>Department of Neurology, King’s College Hospital, London SE5, UK</json:string></affiliations></json:item><json:item><name>S Pal</name><affiliations><json:string>Department of Neurology, King’s College Hospital, London SE5, UK</json:string></affiliations></json:item><json:item><name>A DiMarco</name><affiliations><json:string>Guy’s, King’s and St Thomas’ School of Medicine, King’s College, London, UK</json:string></affiliations></json:item><json:item><name>C Whately-Smith</name><affiliations><json:string>Independent statistician</json:string></affiliations></json:item><json:item><name>K Bridgman</name><affiliations><json:string>Pharmacia Limited, Milton Keynes, UK</json:string></affiliations></json:item><json:item><name>R Mathew</name><affiliations><json:string>Guy’s, King’s and St Thomas’ School of Medicine, King’s College, London, UK</json:string></affiliations></json:item><json:item><name>F R Pezzela</name><affiliations><json:string>Department of Neurological Science, University of Rome La Sapienza, Rome, Italy</json:string></affiliations></json:item><json:item><name>A Forbes</name><affiliations><json:string>University Hospital Lewisham, London, UK</json:string></affiliations></json:item><json:item><name>B Högl</name><affiliations><json:string>Max-Planck Institute of Psychiatry, Munich, Germany</json:string></affiliations></json:item><json:item><name>C Trenkwalder</name><affiliations><json:string>Department of Clinical Neurophysiology, University of Göttingen, Germany</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>Papers</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Drugs: CNS (not psychiatric)</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Sleep disorders (neurology)</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Sleep disorders</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Parkinson’s disease</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>sleep</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>ESS, Epworth sleepiness scale</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>MESS, modified Epworth sleepiness scale</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>PDSS, Parkinson’s disease sleep scale</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>PSQI, Pittsburgh sleep quality index</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>UPDRS, unified Parkinson’s disease rating scale</value></json:item></subject><language><json:string>eng</json:string></language><abstract>Background: No formal instruments are available for quantifying sleep problems in Parkinson’s disease. Objective: To develop a new sleep scale to quantify the various aspects of nocturnal sleep problems in Parkinson’s disease, which may occur in up to 96% of affected individuals. Methods: Employing a multidisciplinary team approach, a visual analogue scale was devised addressing 15 commonly reported symptoms associated with sleep disturbance in Parkinson’s disease—the Parkinson’s disease sleep scale (PDSS). In all, 143 patients with Parkinson’s disease completed the PDSS, covering the entire spectrum of disease from newly diagnosed to advanced stage. As controls, 137 age healthy matched subjects also completed the scale. Test–retest reliability was assessed in a subgroup of subjects. The Epworth sleepiness scale was also satisfactorily completed by 103 of the patients with Parkinson’s disease. Results: PDSS scores in the Parkinson group were significantly different from the healthy controls. Patients with advanced Parkinson’s disease had impaired scores compared with early/moderate disease. Individual items of the scale showed good discriminatory power between Parkinson’s disease and healthy controls. Relevant items of the PDSS correlated with excessive daytime sleepiness. The scale showed robust test–retest reliability. Conclusions: This appears to be the first description of a simple bedside screening instrument for evaluation of sleep disturbances in Parkinson’s disease. A combination of subitems may help identify specific aspects of sleep disturbance, which in turn may help target treatment.</abstract><qualityIndicators><score>7.354</score><pdfVersion>1.1</pdfVersion><pdfPageSize>612 x 792 pts (letter)</pdfPageSize><refBibsNative>false</refBibsNative><keywordCount>11</keywordCount><abstractCharCount>1622</abstractCharCount><pdfWordCount>4630</pdfWordCount><pdfCharCount>30449</pdfCharCount><pdfPageCount>7</pdfPageCount><abstractWordCount>227</abstractWordCount></qualityIndicators><title>The Parkinson’s disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson’s disease</title><pmid><json:string>12438461</json:string></pmid><genre><json:string>research-article</json:string></genre><host><volume>73</volume><pages><first>629</first></pages><issn><json:string>0022-3050</json:string></issn><issue>6</issue><genre></genre><language><json:string>unknown</json:string></language><eissn><json:string>1468-330X</json:string></eissn><title>Journal of Neurology, Neurosurgery & Psychiatry</title></host><publicationDate>2002</publicationDate><copyrightDate>2002</copyrightDate><doi><json:string>10.1136/jnnp.73.6.629</json:string></doi><id>60DA121F2B316A7BC4360ED2A4674FD4E4DA64E4</id><fulltext><json:item><original>true</original><mimetype>application/pdf</mimetype><extension>pdf</extension><uri>https://api.istex.fr/document/60DA121F2B316A7BC4360ED2A4674FD4E4DA64E4/fulltext/pdf</uri></json:item><json:item><original>false</original><mimetype>application/zip</mimetype><extension>zip</extension><uri>https://api.istex.fr/document/60DA121F2B316A7BC4360ED2A4674FD4E4DA64E4/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/60DA121F2B316A7BC4360ED2A4674FD4E4DA64E4/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">The Parkinson’s disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson’s disease</title><respStmt xml:id="ISTEX-API" resp="Références bibliographiques récupérées via GROBID" name="ISTEX-API (INIST-CNRS)"></respStmt></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>BMJ Publishing Group Ltd</publisher><availability><p>BMJ</p></availability><date>2002-12-01</date></publicationStmt><notesStmt><note>Correspondence to:
Dr K R Chaudhuri, Department of Neurology, King’s College Hospital, Denmark Hill, London, SE5 9RS;
ray.chaudhuri@kingshc.nhs.uk</note></notesStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">The Parkinson’s disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson’s disease</title><author><persName><forename type="first">K R</forename><surname>Chaudhuri</surname></persName><affiliation>Department of Neurology, King’s College Hospital, London SE5, UK</affiliation></author><author><persName><forename type="first">S</forename><surname>Pal</surname></persName><affiliation>Department of Neurology, King’s College Hospital, London SE5, UK</affiliation></author><author><persName><forename type="first">A</forename><surname>DiMarco</surname></persName><affiliation>Guy’s, King’s and St Thomas’ School of Medicine, King’s College, London, UK</affiliation></author><author><persName><forename type="first">C</forename><surname>Whately-Smith</surname></persName><affiliation>Independent statistician</affiliation></author><author><persName><forename type="first">K</forename><surname>Bridgman</surname></persName><affiliation>Pharmacia Limited, Milton Keynes, UK</affiliation></author><author><persName><forename type="first">R</forename><surname>Mathew</surname></persName><affiliation>Guy’s, King’s and St Thomas’ School of Medicine, King’s College, London, UK</affiliation></author><author><persName><forename type="first">F R</forename><surname>Pezzela</surname></persName><affiliation>Department of Neurological Science, University of Rome La Sapienza, Rome, Italy</affiliation></author><author><persName><forename type="first">A</forename><surname>Forbes</surname></persName><affiliation>University Hospital Lewisham, London, UK</affiliation></author><author><persName><forename type="first">B</forename><surname>Högl</surname></persName><affiliation>Max-Planck Institute of Psychiatry, Munich, Germany</affiliation></author><author><persName><forename type="first">C</forename><surname>Trenkwalder</surname></persName><affiliation>Department of Clinical Neurophysiology, University of Göttingen, Germany</affiliation></author></analytic><monogr><title level="j">Journal of Neurology, Neurosurgery & Psychiatry</title><title level="j" type="abbrev">J Neurol Neurosurg Psychiatry</title><idno type="pISSN">0022-3050</idno><idno type="eISSN">1468-330X</idno><imprint><publisher>BMJ Publishing Group Ltd</publisher><date type="published" when="2002-12"></date><biblScope unit="volume">73</biblScope><biblScope unit="issue">6</biblScope><biblScope unit="page" from="629">629</biblScope></imprint></monogr><idno type="istex">60DA121F2B316A7BC4360ED2A4674FD4E4DA64E4</idno><idno type="DOI">10.1136/jnnp.73.6.629</idno><idno type="href">jnnp-73-629.pdf</idno><idno type="PMID">12438461</idno><idno type="local">0730629</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>2002-12-01</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>Background: No formal instruments are available for quantifying sleep problems in Parkinson’s disease. Objective: To develop a new sleep scale to quantify the various aspects of nocturnal sleep problems in Parkinson’s disease, which may occur in up to 96% of affected individuals. Methods: Employing a multidisciplinary team approach, a visual analogue scale was devised addressing 15 commonly reported symptoms associated with sleep disturbance in Parkinson’s disease—the Parkinson’s disease sleep scale (PDSS). In all, 143 patients with Parkinson’s disease completed the PDSS, covering the entire spectrum of disease from newly diagnosed to advanced stage. As controls, 137 age healthy matched subjects also completed the scale. Test–retest reliability was assessed in a subgroup of subjects. The Epworth sleepiness scale was also satisfactorily completed by 103 of the patients with Parkinson’s disease. Results: PDSS scores in the Parkinson group were significantly different from the healthy controls. Patients with advanced Parkinson’s disease had impaired scores compared with early/moderate disease. Individual items of the scale showed good discriminatory power between Parkinson’s disease and healthy controls. Relevant items of the PDSS correlated with excessive daytime sleepiness. The scale showed robust test–retest reliability. Conclusions: This appears to be the first description of a simple bedside screening instrument for evaluation of sleep disturbances in Parkinson’s disease. A combination of subitems may help identify specific aspects of sleep disturbance, which in turn may help target treatment.</p></abstract><textClass><keywords scheme="keyword"><list><head>hwp-journal-coll</head><item><term>Drugs: CNS (not psychiatric)</term></item></list></keywords></textClass><textClass><keywords scheme="keyword"><list><head>hwp-journal-coll</head><item><term>Sleep disorders (neurology)</term></item></list></keywords></textClass><textClass><keywords scheme="keyword"><list><head>hwp-journal-coll</head><item><term>Sleep disorders</term></item></list></keywords></textClass><textClass xml:lang="en"><keywords scheme="keyword"><list><head>KWD</head><item><term>Parkinson’s disease</term></item><item><term>sleep</term></item></list></keywords></textClass><textClass xml:lang="en"><keywords scheme="keyword"><list><head>ABR</head><item><term>ESS, Epworth sleepiness scale</term></item><item><term>MESS, modified Epworth sleepiness scale</term></item><item><term>PDSS, Parkinson’s disease sleep scale</term></item><item><term>PSQI, Pittsburgh sleep quality index</term></item><item><term>UPDRS, unified Parkinson’s disease rating scale</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="2002-12-01">Created</change><change when="2002-12">Published</change><change xml:id="refBibs-istex" who="#ISTEX-API" when="2016-3-14">References added</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><original>false</original><mimetype>text/plain</mimetype><extension>txt</extension><uri>https://api.istex.fr/document/60DA121F2B316A7BC4360ED2A4674FD4E4DA64E4/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="corpus bmj" wicri:toSee="no header"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="no"</istex:xmlDeclaration><istex:docType PUBLIC="-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" URI="archivearticle.dtd" name="istex:docType"></istex:docType><istex:document><article xml:lang="en" article-type="research-article"><front><journal-meta><journal-id journal-id-type="hwp">jnnp</journal-id><journal-id journal-id-type="nlm-ta">J Neurol Neurosurg Psychiatry</journal-id><journal-title>Journal of Neurology, Neurosurgery & Psychiatry</journal-title><abbrev-journal-title abbrev-type="publisher">J Neurol Neurosurg Psychiatry</abbrev-journal-title><issn pub-type="ppub">0022-3050</issn><issn pub-type="epub">1468-330X</issn><publisher><publisher-name>BMJ Publishing Group Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="other">0730629</article-id><article-id pub-id-type="other">jnnp;73/6/629</article-id><article-id pub-id-type="doi">10.1136/jnnp.73.6.629</article-id><article-id pub-id-type="pmid">12438461</article-id><article-id pub-id-type="other">629</article-id><article-id pub-id-type="other">jnnp.73.6.629</article-id><article-categories><subj-group subj-group-type="heading"><subject content-type="original">Papers</subject></subj-group><subj-group subj-group-type="hwp-journal-coll"><subject>Drugs: CNS (not psychiatric)</subject></subj-group><subj-group subj-group-type="hwp-journal-coll"><subject>Sleep disorders (neurology)</subject></subj-group><subj-group subj-group-type="hwp-journal-coll"><subject>Sleep disorders</subject></subj-group></article-categories><title-group><article-title>The Parkinson’s disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson’s disease</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Chaudhuri</surname><given-names>K R</given-names></name><xref rid="AFF1">1</xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Pal</surname><given-names>S</given-names></name><xref rid="AFF1">1</xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>DiMarco</surname><given-names>A</given-names></name><xref rid="AFF3">3</xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Whately-Smith</surname><given-names>C</given-names></name><xref rid="AFF8">8</xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Bridgman</surname><given-names>K</given-names></name><xref rid="AFF6">6</xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mathew</surname><given-names>R</given-names></name><xref rid="AFF3">3</xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Pezzela</surname><given-names>F R</given-names></name><xref rid="AFF5">5</xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Forbes</surname><given-names>A</given-names></name><xref rid="AFF2">2</xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Högl</surname><given-names>B</given-names></name><xref rid="AFF7">7</xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Trenkwalder</surname><given-names>C</given-names></name><xref rid="AFF4">4</xref></contrib><aff id="AFF1"><label>1</label>Department of Neurology, King’s College Hospital, London SE5, UK </aff><aff id="AFF2"><label>2</label>University Hospital Lewisham, London, UK </aff><aff id="AFF3"><label>3</label>Guy’s, King’s and St Thomas’ School of Medicine, King’s College, London, UK </aff><aff id="AFF4"><label>4</label>Department of Clinical Neurophysiology, University of Göttingen, Germany </aff><aff id="AFF5"><label>5</label>Department of Neurological Science, University of Rome La Sapienza, Rome, Italy </aff><aff id="AFF6"><label>6</label>Pharmacia Limited, Milton Keynes, UK </aff><aff id="AFF7"><label>7</label>Max-Planck Institute of Psychiatry, Munich, Germany </aff><aff id="AFF8"><label>8</label>Independent statistician</aff></contrib-group><author-notes><corresp>Correspondence to:
Dr K R Chaudhuri, Department of Neurology, King’s College Hospital, Denmark Hill, London, SE5 9RS;
<ext-link xlink:href="ray.chaudhuri@kingshc.nhs.uk" ext-link-type="email" xlink:type="simple">ray.chaudhuri@kingshc.nhs.uk</ext-link></corresp></author-notes><pub-date pub-type="ppub"><month>12</month><year>2002</year></pub-date><pub-date pub-type="epub"><day>1</day><month>12</month><year>2002</year></pub-date><volume>73</volume><volume-id pub-id-type="other">73</volume-id><volume-id pub-id-type="other">73</volume-id><issue>6</issue><issue-id pub-id-type="other">jnnp;73/6</issue-id><issue-id pub-id-type="other">6</issue-id><issue-id pub-id-type="other">73/6</issue-id><fpage>629</fpage><history><date date-type="accepted"><day>20</day><month>08</month><year>2002</year></date><date date-type="received"><day>30</day><month>04</month><year>2002</year></date><date date-type="rev-recd"><day>19</day><month>07</month><year>2002</year></date></history><permissions><copyright-statement>Copyright 2002 Journal of Neurology Neurosurgery and Psychiatry</copyright-statement><copyright-year>2002</copyright-year></permissions><self-uri content-type="pdf" xlink:role="full-text" xlink:href="jnnp-73-629.pdf"></self-uri><abstract xml:lang="en"><p><bold>Background:</bold> No formal instruments are available for quantifying sleep problems in Parkinson’s disease.</p><p><bold>Objective:</bold> To develop a new sleep scale to quantify the various aspects of nocturnal sleep problems in Parkinson’s disease, which may occur in up to 96% of affected individuals.</p><p><bold>Methods:</bold> Employing a multidisciplinary team approach, a visual analogue scale was devised addressing 15 commonly reported symptoms associated with sleep disturbance in Parkinson’s disease—the Parkinson’s disease sleep scale (PDSS). In all, 143 patients with Parkinson’s disease completed the PDSS, covering the entire spectrum of disease from newly diagnosed to advanced stage. As controls, 137 age healthy matched subjects also completed the scale. Test–retest reliability was assessed in a subgroup of subjects. The Epworth sleepiness scale was also satisfactorily completed by 103 of the patients with Parkinson’s disease.</p><p><bold>Results:</bold> PDSS scores in the Parkinson group were significantly different from the healthy controls. Patients with advanced Parkinson’s disease had impaired scores compared with early/moderate disease. Individual items of the scale showed good discriminatory power between Parkinson’s disease and healthy controls. Relevant items of the PDSS correlated with excessive daytime sleepiness. The scale showed robust test–retest reliability.</p><p><bold>Conclusions:</bold> This appears to be the first description of a simple bedside screening instrument for evaluation of sleep disturbances in Parkinson’s disease. A combination of subitems may help identify specific aspects of sleep disturbance, which in turn may help target treatment.</p></abstract><kwd-group kwd-group-type="KWD" xml:lang="en"><kwd>Parkinson’s disease</kwd><kwd>sleep</kwd></kwd-group><kwd-group kwd-group-type="ABR" xml:lang="en"><kwd>ESS, Epworth sleepiness scale</kwd><kwd>MESS, modified Epworth sleepiness scale</kwd><kwd>PDSS, Parkinson’s disease sleep scale</kwd><kwd>PSQI, Pittsburgh sleep quality index</kwd><kwd>UPDRS, unified Parkinson’s disease rating scale</kwd></kwd-group></article-meta></front></article></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>The Parkinson’s disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson’s disease</title></titleInfo><titleInfo type="alternative" lang="en" contentType="CDATA"><title>The Parkinson’s disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson’s disease</title></titleInfo><name type="personal"><namePart type="given">K R</namePart><namePart type="family">Chaudhuri</namePart><affiliation>Department of Neurology, King’s College Hospital, London SE5, UK</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Pal</namePart><affiliation>Department of Neurology, King’s College Hospital, London SE5, UK</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">DiMarco</namePart><affiliation>Guy’s, King’s and St Thomas’ School of Medicine, King’s College, London, UK</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C</namePart><namePart type="family">Whately-Smith</namePart><affiliation>Independent statistician</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">K</namePart><namePart type="family">Bridgman</namePart><affiliation>Pharmacia Limited, Milton Keynes, UK</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R</namePart><namePart type="family">Mathew</namePart><affiliation>Guy’s, King’s and St Thomas’ School of Medicine, King’s College, London, UK</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F R</namePart><namePart type="family">Pezzela</namePart><affiliation>Department of Neurological Science, University of Rome La Sapienza, Rome, Italy</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Forbes</namePart><affiliation>University Hospital Lewisham, London, UK</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B</namePart><namePart type="family">Högl</namePart><affiliation>Max-Planck Institute of Psychiatry, Munich, Germany</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C</namePart><namePart type="family">Trenkwalder</namePart><affiliation>Department of Clinical Neurophysiology, University of Göttingen, Germany</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="research-article" displayLabel="research-article"></genre><subject><genre>hwp-journal-coll</genre><topic>Drugs: CNS (not psychiatric)</topic></subject><subject><genre>hwp-journal-coll</genre><topic>Sleep disorders (neurology)</topic></subject><subject><genre>hwp-journal-coll</genre><topic>Sleep disorders</topic></subject><originInfo><publisher>BMJ Publishing Group Ltd</publisher><dateIssued encoding="w3cdtf">2002-12</dateIssued><dateCreated encoding="w3cdtf">2002-12-01</dateCreated><copyrightDate encoding="w3cdtf">2002</copyrightDate></originInfo><language><languageTerm type="code" authority="iso639-2b">eng</languageTerm><languageTerm type="code" authority="rfc3066">en</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType></physicalDescription><abstract lang="en">Background: No formal instruments are available for quantifying sleep problems in Parkinson’s disease. Objective: To develop a new sleep scale to quantify the various aspects of nocturnal sleep problems in Parkinson’s disease, which may occur in up to 96% of affected individuals. Methods: Employing a multidisciplinary team approach, a visual analogue scale was devised addressing 15 commonly reported symptoms associated with sleep disturbance in Parkinson’s disease—the Parkinson’s disease sleep scale (PDSS). In all, 143 patients with Parkinson’s disease completed the PDSS, covering the entire spectrum of disease from newly diagnosed to advanced stage. As controls, 137 age healthy matched subjects also completed the scale. Test–retest reliability was assessed in a subgroup of subjects. The Epworth sleepiness scale was also satisfactorily completed by 103 of the patients with Parkinson’s disease. Results: PDSS scores in the Parkinson group were significantly different from the healthy controls. Patients with advanced Parkinson’s disease had impaired scores compared with early/moderate disease. Individual items of the scale showed good discriminatory power between Parkinson’s disease and healthy controls. Relevant items of the PDSS correlated with excessive daytime sleepiness. The scale showed robust test–retest reliability. Conclusions: This appears to be the first description of a simple bedside screening instrument for evaluation of sleep disturbances in Parkinson’s disease. A combination of subitems may help identify specific aspects of sleep disturbance, which in turn may help target treatment.</abstract><note type="author-notes">Correspondence to:
Dr K R Chaudhuri, Department of Neurology, King’s College Hospital, Denmark Hill, London, SE5 9RS;
ray.chaudhuri@kingshc.nhs.uk</note><subject lang="en"><genre>KWD</genre><topic>Parkinson’s disease</topic><topic>sleep</topic></subject><subject lang="en"><genre>ABR</genre><topic>ESS, Epworth sleepiness scale</topic><topic>MESS, modified Epworth sleepiness scale</topic><topic>PDSS, Parkinson’s disease sleep scale</topic><topic>PSQI, Pittsburgh sleep quality index</topic><topic>UPDRS, unified Parkinson’s disease rating scale</topic></subject><relatedItem type="host"><titleInfo><title>Journal of Neurology, Neurosurgery & Psychiatry</title></titleInfo><titleInfo type="abbreviated"><title>J Neurol Neurosurg Psychiatry</title></titleInfo><genre type="Journal">journal</genre><identifier type="ISSN">0022-3050</identifier><identifier type="eISSN">1468-330X</identifier><identifier type="PublisherID-hwp">jnnp</identifier><identifier type="PublisherID-nlm-ta">J Neurol Neurosurg Psychiatry</identifier><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>73</number></detail><detail type="issue"><caption>no.</caption><number>6</number></detail><extent unit="pages"><start>629</start></extent></part></relatedItem><identifier type="istex">60DA121F2B316A7BC4360ED2A4674FD4E4DA64E4</identifier><identifier type="DOI">10.1136/jnnp.73.6.629</identifier><identifier type="href">jnnp-73-629.pdf</identifier><identifier type="PMID">12438461</identifier><identifier type="local">0730629</identifier><accessCondition type="use and reproduction" contentType="copyright">Copyright 2002 Journal of Neurology Neurosurgery and Psychiatry</accessCondition><recordInfo><recordContentSource>BMJ</recordContentSource></recordInfo></mods></metadata><annexes><json:item><original>true</original><mimetype>image/jpeg</mimetype><extension>jpeg</extension><uri>https://api.istex.fr/document/60DA121F2B316A7BC4360ED2A4674FD4E4DA64E4/annexes/jpeg</uri></json:item></annexes><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000B93 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000B93 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= ISTEX:60DA121F2B316A7BC4360ED2A4674FD4E4DA64E4
|texte= The Parkinson’s disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson’s disease
}}
| This area was generated with Dilib version V0.6.23. |  |